8:30 – 8:40 am

8:40 – 9:10 am

Welcome and Opening Remarks

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Web K. Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor Emeritus, University of California, San Diego

Keynote Speech

James P. Allison, Ph.D.

Professor & Chair of Immunology, Executive Director of Immunotherapy Platform, The University of Texas MD Anderson Cancer Center
2014 Szent-Györgyi Prize Winner
2018 Nobel Prize Winner

9:10 – 10:30 am

Session I: New Approaches to Cancer Treatments

Moderator:

Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University

Panel Members:

• Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard
• Avery D. Posey, Ph.D., Assistant Professor, University of Pennsylvania Perelman School of Medicine
• Azra Raza, M.D., Chan Soon-Shiong Professor of Medicine, Columbia University in New York
• Pam Sharma, M.D., Ph.D., Professor of Genitourinary Medical Oncology and Immunology, The University of Texas MD Anderson Cancer Center
• Thea D. Tlsty, Ph.D., Professor of Pathology, University of California San Francisco

10:45 am – 11:35 am

Session II: Panel Discussion on Precision Medicine

Moderator:

Brian Leyland-Jones, MBBS, Ph.D., Chief Medical Officer, AIM-HI Accelerator Fund

Panel Members: 

• Lon Cardon, Ph.D., President and CEO, The Jackson Laboratory
• Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Harvard Medical School
• Anna D. Barker, Ph.D., Chief Strategy Officer, Ellison Institute for Transformative Medicine
• Min Li, Ph.D., Professor of Medicine, Surgery and Cell Biology, The University of Oklahoma
• Massimo Cristofanilli, M.D., Chief, Breast Medical Oncology, Weil Cornell Medicine

11:35 am – 12:30 pm

Session III: Szent-Gyorgyi Prize Panel Discussion on Status of Cancer Biology

Moderator:

Doug R. Lowy, M.D., Principal Deputy Director, National Cancer Institute

Panel Members: 

• Carlo M. Croce, M.D., John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University
• Web K. Cavenee, Ph.D., Distinguished Professor Emeritus, University of California, San Diego
• Rakesh Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School
• Peter K. Vogt, Ph.D., Professor Emeritus of Molecular Medicine, Scripps Research

12:20 – 12:25 pm

Closing Remarks: 

Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology

6:00 – 7:00 pm

Cocktail Reception

7:00 – 8:30 pm

Dinner Award Ceremony

Moment of Silence

Opening and Welcome Remarks:

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

Keynote Speech:

Helmut Sies, M.D., Professor Emeritus, Department of Biochemistry and Molecular Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Introduction of the 2023 Szent-Györgyi Prize Winner:

Rakesh K. Jain, Ph.D., 2022 Szent-Györgyi Prize Winner & Chair of the 2023 Selection Committee for the Szent-Györgyi Prize; Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Award Trophy Presentation: 

Dr. Sujuan Ba, Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

2023 Szent-Györgyi Prize Winner Award Speech: 

Isaac P. Witz, Ph.D., Professor Emeritus at Tel Aviv University, Head of the Laboratory of Tumor Microenvironment & Metastasis Research at The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences

Acknowledgments & Closing Remarks: 

Alfred Slanetz, Chair of the Board, NFCR; CEO of Geneius Biotechnology